A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking ...
1d
CD Bioparticles Announces Advanced Engineering Platform for OMV-Based Bacterial Vaccine Development
CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and ...
Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as ...
Pharmaceutical Technology on MSN
WHO wants improved universal vaccines to win global influenza battle
Analysis by WHO estimates that 6.2 million lives could be saved if next-generation vaccines are used through to 2050.
Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...
THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government ...
The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results